Norberto Krivoy

1.7k total citations
90 papers, 1.1k citations indexed

About

Norberto Krivoy is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Epidemiology. According to data from OpenAlex, Norberto Krivoy has authored 90 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pediatrics, Perinatology and Child Health, 17 papers in Pharmacology and 16 papers in Epidemiology. Recurrent topics in Norberto Krivoy's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Acute Lymphoblastic Leukemia research (11 papers) and Pharmaceutical studies and practices (9 papers). Norberto Krivoy is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Acute Lymphoblastic Leukemia research (11 papers) and Pharmaceutical studies and practices (9 papers). Norberto Krivoy collaborates with scholars based in Israel, United States and Germany. Norberto Krivoy's co-authors include Elon Eisenberg, Edna Efrati, Zaher S. Azzam, Jacob M. Rowe, Yaron River, Erica Hoffer, Eli Sprecher, Ronit Elhasid, M. Weyl Ben Arush and Sergey Postovsky and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Norberto Krivoy

88 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norberto Krivoy Israel 20 247 180 176 165 163 90 1.1k
T Pullar United Kingdom 21 226 0.9× 95 0.5× 112 0.6× 96 0.6× 202 1.2× 51 1.5k
M. Godin France 22 188 0.8× 258 1.4× 56 0.3× 149 0.9× 128 0.8× 94 1.4k
Donald P. Reitberg United States 13 233 0.9× 204 1.1× 57 0.3× 164 1.0× 76 0.5× 26 1.1k
Prem K. Narang United States 14 144 0.6× 126 0.7× 223 1.3× 96 0.6× 207 1.3× 37 856
Noël Zahr France 23 213 0.9× 279 1.6× 123 0.7× 288 1.7× 99 0.6× 64 1.8k
Elizabeth Ludwig United States 19 239 1.0× 124 0.7× 98 0.6× 105 0.6× 173 1.1× 59 1.1k
Donald F. LeGatt Canada 18 209 0.8× 300 1.7× 61 0.3× 144 0.9× 140 0.9× 60 1.2k
Fe‐Lin Lin Wu Taiwan 22 155 0.6× 211 1.2× 61 0.3× 180 1.1× 109 0.7× 72 1.3k
Pierre Lafolie Sweden 19 103 0.4× 160 0.9× 261 1.5× 146 0.9× 137 0.8× 39 1.1k
Kaj Anker Jørgensen Denmark 23 92 0.4× 209 1.2× 120 0.7× 190 1.2× 201 1.2× 72 1.6k

Countries citing papers authored by Norberto Krivoy

Since Specialization
Citations

This map shows the geographic impact of Norberto Krivoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norberto Krivoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norberto Krivoy more than expected).

Fields of papers citing papers by Norberto Krivoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norberto Krivoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norberto Krivoy. The network helps show where Norberto Krivoy may publish in the future.

Co-authorship network of co-authors of Norberto Krivoy

This figure shows the co-authorship network connecting the top 25 collaborators of Norberto Krivoy. A scholar is included among the top collaborators of Norberto Krivoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norberto Krivoy. Norberto Krivoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avivi, Irit, Tsila Zuckerman, Norberto Krivoy, & Edna Efrati. (2013). Genetic polymorphisms predicting methotrexate blood levels and toxicity in adult non-Hodgkin lymphoma. Leukemia & lymphoma. 55(3). 565–570. 22 indexed citations
2.
3.
4.
Hardak, Emília, Gidon Berger, Norberto Krivoy, Anna Solomonov, & Mordechai Yigla. (2010). Nitrofurantoin Pulmonary Toxicity: Neglected Threat. Current Drug Safety. 5(2). 125–128. 4 indexed citations
5.
Ameer, Barbara & Norberto Krivoy. (2009). Direct‐to‐Consumer/Patient Advertising of Genetic Testing: A Position Statement of the American College of Clinical Pharmacology. The Journal of Clinical Pharmacology. 49(8). 886–888. 19 indexed citations
6.
Kassis, Imad, et al.. (2009). General medications utilization and cost patterns in hospitalized children. Pharmacy Practice. 7(1). 54–8. 4 indexed citations
7.
Krivoy, Norberto, Erica Hoffer, Yael Lurie, Yedidia Bentur, & Jacob M. Rowe. (2008). Busulfan Use in Hematopoietic Stem Cell Transplantation: Pharmacology, Dose Adjustment, Safety and Efficacy in Adults and Children. Current Drug Safety. 3(1). 60–66. 49 indexed citations
8.
Neuman, Manuela G., Neil H. Shear, Izabella M. Malkiewicz, et al.. (2007). Immunopathogenesis of hypersensitivity syndrome reactions to sulfonamides. Translational research. 149(5). 243–253. 21 indexed citations
9.
Azzam, Zaher S., Yochai Adir, Lynn C. Welch, et al.. (2006). Alveolar fluid reabsorption is increased in rats with compensated heart failure. American Journal of Physiology-Lung Cellular and Molecular Physiology. 291(5). L1094–L1100. 17 indexed citations
10.
Shahar, Eduardo, Norberto Krivoy, Sara Weltfriend, & Shimon Pollack. (2004). Severe Leukopenia Associated with Mild Hepatotoxicity in an HIV Carrier Treated with Nevirapine. Japanese Journal of Infectious Diseases. 57(5). 212–213. 2 indexed citations
11.
Azzam, Zaher S., Yochai Adir, Astrid Crespo‐Lessmann, et al.. (2004). Norepinephrine Increases Alveolar Fluid Reabsorption and Na,K-ATPase Activity. American Journal of Respiratory and Critical Care Medicine. 170(7). 730–736. 24 indexed citations
12.
Azzam, Zaher S., et al.. (2004). Antibiotic utilization prevalence: prospective comparison between two medical departments in a tertiary care university hospital. Pharmacoepidemiology and Drug Safety. 13(10). 735–739. 9 indexed citations
13.
Krivoy, Norberto, Erica Hoffer, Ronit Elhasid, et al.. (2002). THERAPEUTIC MONITORING OF BUSULFAN IN PEDIATRIC BONE MARROW TRANSPLANTATION. Pediatric Hematology and Oncology. 19(1). 31–37. 12 indexed citations
14.
Yigla, Mordechai, Eli Sprecher, Zaher S. Azzam, et al.. (2000). Diffuse Alveolar Hemorrhage following Thrombolytic Therapy for Acute Myocardial Infarction. Respiration. 67(4). 445–448. 11 indexed citations
15.
Baruch, Yaacov, et al.. (1998). Spontaneous pulsatility and pharmacokinectics of growth hormone in liver cirrhotic patients. Journal of Hepatology. 29(4). 559–564. 14 indexed citations
16.
Azzam, Zaher S., Norberto Krivoy, G Alroy, & Oren Zinder. (1994). Serum Creatine Kinase Levels after a Single Intramuscular Injection—Dependence on Injection Volume. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 31(2). 193–194. 4 indexed citations
17.
Jakobi, Peter, et al.. (1991). Endogenous Digoxin-Like Immunoreactivity in FoUicular Fluid and in vitro Fertilization. Gynecologic and Obstetric Investigation. 32(4). 193–195. 1 indexed citations
18.
Krivoy, Norberto, Peter Jakobi, E Paldi, & G Alroy. (1990). Total digoxin-like immunoreactive factor(s) in healthy population, uncomplicated term pregnancies and neonates. Journal of Endocrinological Investigation. 13(1). 9–12. 6 indexed citations
19.
Zimmer, Etan Z., et al.. (1990). Maternal and fetal digoxin-like immunoreactive factor in elective Cesarean sections and spontaneous vaginal delivery. European Journal of Obstetrics & Gynecology and Reproductive Biology. 36(1-2). 53–58. 3 indexed citations
20.
Krivoy, Norberto, et al.. (1981). Relationship between digoxin concentration in serum and saliva in infants. The Journal of Pediatrics. 99(5). 810–811. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Pullar Breakdown of academic impact, for papers by M. Godin Breakdown of academic impact, for papers by Donald P. Reitberg Breakdown of academic impact, for papers by Prem K. Narang Breakdown of academic impact, for papers by Noël Zahr Breakdown of academic impact, for papers by Elizabeth Ludwig Breakdown of academic impact, for papers by Donald F. LeGatt Breakdown of academic impact, for papers by Fe‐Lin Lin Wu Breakdown of academic impact, for papers by Pierre Lafolie Breakdown of academic impact, for papers by Kaj Anker Jørgensen
Rankless by CCL
2026